Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-262-8 | CAS number: 56-23-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- sub-chronic toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline-compliant study,good qualitiy study, Klimisk 1 even no data on GLP status.
Data source
Reference
- Reference Type:
- publication
- Title:
- Thirteen-week inhalation toxicity of carbon tetrachloride in rats and mice
- Author:
- Nagano K, Umeda, Saito, Nishizawa, Ikawa, Arito H, Yamamoto S, Fukushima S;
- Year:
- 2 007
- Bibliographic source:
- J Occup Health 2007; 49: 249-259
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 413 (Subchronic Inhalation Toxicity: 90-Day Study)
- Deviations:
- no
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Carbon tetrachloride
- EC Number:
- 200-262-8
- EC Name:
- Carbon tetrachloride
- Cas Number:
- 56-23-5
- Molecular formula:
- CCl4
- IUPAC Name:
- tetrachloromethane
- Details on test material:
- - Name of test material (as cited in study report): CCl4
- Analytical purity: > 99.8% (Wako Pure Chemical Industries, Ltd., Osaka, Japan)
- Impurities (identity and concentrations): no impurities detected with GC and IR-spectrometry
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, Japan, Inc. (Kanagawa)
- Housing: individually in stainless steel wire hanging cages (150 mm x 216 mm x 176 mm)
- Diet (e.g. ad libitum): sterilized commercial pellet diet (CRF-1, Orienal Yeast Co., Tokyo) ad libidum
- Water (e.g. ad libitum): sterilized drinking water, ad libidum
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24.5 - 25.1°C
- Humidity (%): 52.3 - 57.1%
- Air changes (per hr): 12-15
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Remarks on MMAD:
- MMAD / GSD: not applicable, vapour of a volatile organic solvent
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: exposure chamber (4.3 cbm, glass and stainless steal) maximal load: 50 stainless steal wire mesh cages
- Method of holding animals in test chamber: stainless steal wire mesh cages, animals individualIy housed
- Source and rate of air: not reported
- Method of conditioning air: not reported
- System of generating vapor: vapor-air mixture was generated by bubbling clean air through liquid of CTC in a temperature-regulated glass flask, and by cooling it through a thermostatted condensor.The airflow containing the saturated vapor was diluted with clean air and then warmed in a thermostatted circulator which served to stabilize the vapor concentration by complete gasification of CTC and by buffering the pressure difference between the glass flask and the inhalation chamber. The vapor-air mixture flow rate was regulated with a flow meter, further diluted with humidity- and temperature-controlled clean air in a spiraling line mixer, and then supplied to the inhalation exposure chamber.
- Temperature, humidity, pressure in air chamber: 22 ± 2 °C, 55 ± 10 %, - 50 to - 150 Pa
- Air flow rate: 860 l/min
- Air change rate: 12 changes/h
- Method of particle size determination: not applicable (vapor of volatile solvent)
- Treatment of exhaust air: not reported
TEST ATMOSPHERE
- Brief description of analytical method used: Chamber concentrations of CTC vapor were monitored by gas chromatography once every 15 min.
- Samples taken from breathing zone: yes
VEHICLE
- No - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- - gas chromatography, sampling every 15 min during exposure, no further details given
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 6 hrs/day
5 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
64, 192, 576, 1728 and 5184 mg/m³ (10, 30, 90, 270 and 810 ppm)
Basis:
analytical conc.
- No. of animals per sex per dose:
- 10 males and 10 females
- Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: the lowest inhalation concentration of 64 mg/m³ (10 ppm) was selected in consideration of the validity of the present occupational exposure limit (OEL) value for CCld
- Rationale for animal assignment (if not random): not reported
- Rationale for selecting satellite groups: no satellite groups
- Post-exposure recovery period in satellite groups: not applicable
- Section schedule rationale (if not random): not reported - Positive control:
- Not applied
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes (see Table 1)
- Time schedule for examinations: once a week
FOOD CONSUMPTION:
- Food consumption for each animal determined: Yes
FOOD EFFICIENCY: No data
WATER CONSUMPTION: No data
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: in the last week of the 13-wk exposure period
- Anaesthetic used for blood collection: Yes (ether)
- Animals fasted: Yes (overnight)
- How many animals: no data
- Parameters checked in table No. 2 were examined.
- further not-reported parameters might have been analyzed, as the authors reference OECD 413
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: in the last week of the 13-wk exposure period
- Animals fasted: Yes (overnight)
- How many animals: no data
- at least Parameters shown in table No. 2 were examined.
- further not-reported parameters might have been analyzed, as the authors reference OECD 413
URINALYSIS: Yes
- Time schedule for collection of urine: in the last week of the 13-wk exposure period
- Animals fasted: No data
- Parameters shown in table No. 2 were examined.
- further not-reported parameters might have been analyzed, as the authors reference OECD 413
NEUROBEHAVIOURAL EXAMINATION: No
RELATIVE ORGANS WEIGHT (see Table 1) - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes (see table No. 3) - Other examinations:
- The livers of 810 ppm-exposed and control groups of male rats were sectioned for examination of hepatic altered cell foci, a preneoplastic lesion, by immunohistochemical staining with anti-GST-P
- Statistics:
- Body weights, organ weights, and haematological and blood biochemical parameters: Dunnett's multiple comparison test with a p-value of 0.05
Pathological examinations and urinary parameters: Chi-square test with a p-value of 0.05
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Clinical biochemistry findings:
- effects observed, treatment-related
- Urinalysis findings:
- effects observed, treatment-related
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY
No death occured in any of the CCl4-exposed rats groups of either sexes
No CCl4-related clinical signs except for soiling of the perigenital and perinasal areas in male and female rats exposed to 270 ppm and above
BODY WEIGHT AND WEIGHT GAIN
Terminal body weight significantly decreased onlyin the 810-ppm exposed male rats
FOOD CONSUMPTION
No data
HAEMATOLOGY
White red blood cell counts significantly decreased in the 810 ppm-exposed rats of both sexes
Hemoglobin and hematocrit significantly decreased in male and female rats at 90 ppm and above
CLINICAL CHEMISTRY
Increase of AST, ALT and LDH in male rats exposed to 90 ppm and above and in female rats exposed to 30 ppm and above (although the increases in
AST and LDH in the 90 ppm-exposed male rats were not statistically significant)
ALP significantly increased in both sexes at 90 ppm and above
Total bilirubin significantly increased in male rats at 810 ppm and in female rats at 270 and 810 ppm.
URINALYSIS
Urinary protein significantly increased in male rats exposed to 270 and 810 ppm and in female rats exposed to 90 ppm and above.
ORGAN WEIGHTS
Significant increase in relative organ weight in livers of male rats exposed to 10 ppm and above and of female rats exposed to 30 ppm and above.
Relative kidney weights significantly increased in male rats exposed to 10 ppm and above, except 30 ppm, and of females exposed to 90 ppm and above.
Biologically meaningful increase in the relative kidney weight occured in both male and female rats exposed to 90 ppm and above (because a dose-dependent increase was observed in rats of both sexes exposed to 90 ppm and above and because the statistically increased relative kidney weight of
10 ppm-exposed male rats was attributed to a marginal decrease in the body weight.
GROSS PATHOLOGY
Granular liver surface in one female exposed to 90 ppm, in five males and 10 females exposed to 270 ppm and all male and female rats exposed to
810 ppm.
HISTOPATHOLOGY: NON-NEOPLASTIC
Non significant increase of fatty change (large droplets, greater in diameter than the hepatocellular nuclei) in 2 males and 2 females rats exposed to 10 ppm. Significant increase of fatty change in both male and female rats exposed to 30 ppm and above. Its averaged severity increased in a dose-dependent manner except for the female groups exposed to 270 and 810 ppm.
Significant increase in the incidence of fibrosis in male rats exposed to 270 and 810 ppm and in females at 90 ppm and above.
Cirrhosis in both male and female rats exposed to 270 and 810 ppm (incidence in the 270 ppm-exposed male rats not statistically significant).
Either fibrosis or cirrhosis was accompanied by increased mitosis and nuclear enlargement of hepatocytes, proliferation of bile duct and deposition of ceroid-like yellow pigment in the connective tissue area.
Altered cell foci, characterized by expansile nodules, in male rats exposed to 270 and 810 ppm, and in female rats at 90 ppm and above (incidences in the 270 ppm male rats and in the 90 ppm exposed females were not statistically significant). The altered cell foci were classified into acidophilic, basophilic or clear cell foci.
The cell foci seen in the 810 ppm-exposed male rats were also stained positively with the anti-GST-P anitobody. The altered cell foci were homogeneously composed of GST-P positive hepatocytes.
Localized glomerulosclerosis significantly increased in both male and female rats exposed to 810 ppm.
No histopathological changes observed in the respiratory tract, including the nasal cavity, larynx, trachea or lungs.
Effect levels
- Dose descriptor:
- LOAEC
- Effect level:
- 64 mg/m³ air (analytical)
- Sex:
- male/female
- Basis for effect level:
- other: LOAEC refered to the endpoints: -liver fatty change with large droplets in rats (male and female), with increase of relative liver weight (in male rats)
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Repeated inhalation exposure of rats of both sexes to CTC vapor at 10 to 810 ppm for 13 wk induced mild to severe hepatoxicity including a preneoplastic lesion, as well as renal and hematological toxicities to a less severe extent. However, inhalation exposure of both sexes to CTC vapor did not produce any histopathological change in the respiratory tracts, including the nasal cavity, larynx, trachea and lungs. The present study confirmed the pathological findings of earlier inhalation studies, by demonstrating the increased liver weight, enhanced release of transaminases into plasma and fatty degeneration, fibrosis and cirrhosis. Inhalation exposure to high levels of CTC for 13 wk induced the hepatic altered cell foci mirrored by GST-P-positively stained hepatocytes as a preneoplastic lesion, while the low levels of CCl4 designated 10ppm for the most sensitive sign as fatty change, cytoplasmic globules and increased liver weight.
Table 1: Terminal body weight, and relative liver and kidney weights of rats exposed to CCl4 vapor by inhalation for 13 wk
Male |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Body weight (g) |
301 |
296 |
304 |
302 |
289 |
244 |
Organ weight |
||||||
Liver (%) |
2.44 |
2.59** |
2.89** |
3.27** |
3.91** |
4.23** |
Kidney (%) |
0.57 |
0.61** |
0.59 |
0.63** |
0.70** |
0.83** |
Contd.
Female |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Body weight (g) |
176 |
178 |
185 |
184 |
175 |
169 |
Organ weight |
||||||
Liver (%) |
2.33 |
2.47 |
3.19** |
4.41** |
4.59** |
4.76** |
Kidney (%) |
0.65 |
0.65 |
0.65 |
0.72** |
0.83** |
0.91** |
Values indicate means. Significant difference; +: p 0.05 **: p0.01 by Dunnett's test.
Table 2. Hematological, blood biochemical and urinary parameters of the rats exposed to CCl4 vapor by inhalation for 13 wk
Male |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
Hematology No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Red blood cell (106/μl) |
10.16 |
10.27 |
10.36 |
10.27 |
10.01 |
7.92** |
Hemoglobin (g/dl) |
17.0 |
17.1 |
16.8 |
16.0** |
14.8** |
12.0 |
Hematocrit (%) |
48.1 |
48.3 |
47.9 |
45.9** |
43.1** |
34.7** |
Blood chemistry No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
AST (IU/l) |
76 |
81 |
79 |
118 |
459** |
1'465** |
ALT (IU/l) |
25 |
27 |
30 |
67** |
303** |
465** |
LDH (IU/l) |
350 |
353 |
335 |
565 |
739* |
642 |
ALP (IU/l) |
266 |
271 |
284 |
294** |
497** |
1'098** |
Total bilirubin (mg/dl) |
0.14 |
0.14 |
0.11 |
0.14 |
0.18 |
0.48 |
Urinalysis No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Protein a |
0 |
0 |
0 |
0 |
7** |
10** |
Contd.
Female |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
Hematology No. of animals examined |
10 |
10 |
9b |
10 |
10 |
10 |
Red blood cell (106/μl) |
9.08 |
9.32 |
9.67** |
9.26 |
9.06 |
8.29** |
Hemoglobin (g/dl) |
16.4 |
16.8 |
16.3 |
15.1** |
14.4** |
12.8** |
Hematocrit (%) |
46.0 |
47.0 |
46.8 |
42.8** |
41.0** |
36.7** |
Blood chemistry No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
AST (IU/l) |
65 |
72 |
100** |
233** |
364** |
897** |
ALT (IU/l) |
19 |
25 |
38** |
111** |
146** |
322** |
LDH (IU/l) |
294 |
265 |
438* |
471** |
501** |
404 |
ALP (IU/l) |
183 |
204 |
196 |
284** |
427** |
725** |
Total bilirubin (mg/dl) |
0.17 |
0.16 |
0.14 |
0.17 |
0.25* |
0.36** |
Urinalysis No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Protein a |
0 |
0 |
0 |
7** |
10** |
10** |
Values indicate means. Significant difference; *: p 0.05 **: p0.01 by Dunnett's test.AST: aspartate aminotransferase, : alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase. a: Number of animals whose urinary protein level exceeded 100 mg/dl was counted. b: blood collection failed for one rat
Table 3. Incidences and severities of selected histopathological lesions in the rats exposed to CCl4 vapor by inhalation for 13 wk
Male |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Liver |
0 |
0 |
0 |
0 |
0 |
0 |
Fatty change: large droplet |
0 |
2 (1.0) |
10** (1.1) |
10** (1.5) |
10** (2.0) |
10** (2.1) |
Fibrosis |
0 |
0 |
0 |
0 |
10** |
10** |
Cirrhosis |
0 |
0 |
0 |
0 |
2 |
10** |
Altered cell foci |
0 |
0 |
0 |
0 |
3 |
10** |
Acidophilic cell foci |
0 |
0 |
0 |
0 |
2 |
7** |
Basophilic cell foci |
0 |
0 |
0 |
0 |
1 |
6** |
Clear cell foci |
0 |
0 |
0 |
0 |
0 |
0 |
Kidney Glomerulosclerosis: localized |
0 |
0 |
0 |
0 |
0 |
10** |
Contd.
Female |
||||||
Group (ppm) |
Control |
10 |
30 |
90 |
270 |
810 |
No. of animals examined |
10 |
10 |
10 |
10 |
10 |
10 |
Liver |
8 (1.0) |
8 (1.0) |
0 |
0 |
0 |
0 |
Fatty change: large droplet |
0 |
2 (1.0) |
10** (2.0) |
10** (2.5) |
10** (2.0) |
10** (1.5) |
Fibrosis |
0 |
0 |
0 |
5** |
5** |
9** |
Cirrhosis |
0 |
0 |
0 |
0 |
10** |
9** |
Altered cell foci |
0 |
0 |
0 |
3 |
10** |
10** |
Acidophilic cell foci |
0 |
0 |
0 |
1 |
6** |
6** |
Basophilic cell foci |
0 |
0 |
0 |
1 |
0 |
0 |
Clear cell foci |
0 |
0 |
0 |
1 |
9** |
10** |
Kidney Glomerulosclerosis: localized |
0 |
0 |
0 |
0 |
0 |
10** |
Values indicate number of animals bearing lesion. The values in parentheses indicate the average of severity grade index of the lesion. The average of severity grade was calculated with the following equation. Σ (grade x number of animals with grade) / number of affected animals. Grade 1=slight, 2=moderate, 3=severe. Significant difference; *: p 0.05 **: p0.01 by chi-square test
Applicant's summary and conclusion
- Conclusions:
- The present study (Nagano 2007) presents for CTC a LOAEC of 64 mg/m³ (10 ppm) in rats for subchronic repeated dose toxicity via inhalation exposure (Treatment: 6 h/d, 5 d/week, 13 weeks)
- Executive summary:
The present study (Nagano 2007) presents for CTC a LOAEC of 64 mg/m³ (10 ppm) in rats for subchronic repeated dose toxicity via inhalation exposure (Treatment: 6 h/d, 5 d/week, 13 weeks). Basis are organ weight effects and fatty change in liver .
Subchronic toxicity of CTC was examined according to OECD guideline 413. F344 rats of both sexes were exposed by inhalation to 0, 10, 30, 90, 270 or 810 ppm (v/v) CTC vapor for 13 wk (6 h/d and 5 d/wk). Body weight development, food consumption and clinical signs were monitored during te course of the study. At the end of treatment, urinary parameters, haematology and clinical chemistry parameters were investigated. Furthermore, all animals underwent full macroscopic anc microscopic pathological evaluation.
In the high exposure levels at 270 and 810 ppm, altered cell foci in the livers, and fibrosis and cirrhosis in the rat liver were observed. Hematoxylin and eosin-stained altered cell foci of rats were recognized as glutathione-S-transferase placental form (GST-P) positive foci, which are preneoplastic lesions of hepatocarcinogenesis. The most sensitive endpoint of CTC-induce toxicity was fatty change with large droplets in rats of both sexes, as well as increased relative liver weight in male rats. Those endpoints were manifested at 10 ppm and the LOAEL was determined as 10 ppm for the hepatic endpoints in rats. Enhanced cytolytic release of liver transaminase into plasma in rats was observed at medium and high levels of inhalation exposure. Both CTC-induced hepatoxicity and nephrotoxicity were observed, but nephrotoxicity was manifested at higher exposure concentrations than hepatotoxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
